aspirin has been researched along with beraprost in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Murata, T; Nishio, S; Osada, E; Tanaka, Y; Umetsu, T | 1 |
| Isogaya, M; Koike, H; Kumagai, H; Nishio, S; Ochi, Y; Okazaki, S; Ueno, Y; Yamada, N | 1 |
| Kawashima, A; Koike, H; Nishio, S; Ueno, Y | 1 |
| Asakura, T; Kanke, M; Maruyama, Y; Owada, K; Saito, T; Saitoh, S | 1 |
| Shirasaki, F; Takata, M; Takehara, K; Tsutsui, K | 1 |
| Annoh, S; Koike, H; Nishio, S; Ueno, Y | 1 |
| Kimura, T; Noda, Y; Okamura, T; Toda, N | 1 |
| Kamei, M; Kinoshita, S; Tei, M; Yamamoto, T; Yasuhara, T; Yokoi, N | 1 |
| Masood, I | 1 |
| Chi, HS; Kim, H; Kim, KM; Kim, SB; Park, JS | 1 |
| Ando, M; Hida, K; Ishida, A; Kawasaki, T; Matsumoto, T; Matsuzaki, K; Miyata, T; Nishibe, T; Obitsu, Y; Ohta, T; Shigematsu, H; Shindo, S; Yasugi, T | 1 |
| Fukasawa, M; Hosokawa, K; Koide, T; Kondo, T; Maruyama, I; Ohnishi, T; Sameshima, H; Tanaka, KA | 1 |
| Chen, S; Chen, W; He, W; Li, S; Wei, D; Xie, S | 1 |
| Chen, SQ; Chen, XP; He, WZ; Wei, DC; Zhang, Q | 1 |
| Chen, Y; Fu, L; Li, J; Lin, X; Lu, W; Ren, M; Yan, L; Yang, C; Yin, J | 1 |
4 trial(s) available for aspirin and beraprost
| Article | Year |
|---|---|
Successful treatment of livedo vasculitis with beraprost sodium: a possible mechanism of thrombomodulin upregulation.
Topics: Adolescent; Adult; Aged; Aspirin; Child; Drug Therapy, Combination; Epidermis; Epoprostenol; Female; Humans; Leg Ulcer; Middle Aged; Platelet Aggregation Inhibitors; Thrombomodulin; Treatment Outcome; Up-Regulation; Vasculitis | 1996 |
Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.
Topics: Aged; Aspirin; Epoprostenol; Female; Humans; Light; Male; Middle Aged; Particle Size; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Retinal Vein Occlusion; Scattering, Radiation; Ticlopidine | 2004 |
Combination therapy with beraprost sodium and aspirin for acute ischemic stroke: a single-center retrospective study.
Topics: Aged; Aspirin; Brain Ischemia; Drug Therapy, Combination; Epoprostenol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Stroke | 2019 |
Ultrasonography evaluation on the protective effect of combination therapy of beraprost sodium and aspirin on arteries occlusion and stiffness in patients with type 2 diabetes mellitus - a prospective, randomized study.
Topics: Arteries; Aspirin; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Epoprostenol; Humans; Prospective Studies; Pulse Wave Analysis; Ultrasonography | 2022 |
12 other study(ies) available for aspirin and beraprost
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antithrombotic effect of TRK-100, a novel, stable PGI2 analogue.
Topics: Animals; Aspirin; Collagen; Epoprostenol; Fibrinolytic Agents; In Vitro Techniques; Male; Platelet Adhesiveness; Rats; Rats, Inbred Strains; Ticlopidine | 1987 |
Inhibition of restenosis by beraprost sodium (a prostaglandin I2 analogue) in the atherosclerotic rabbit artery after angioplasty.
Topics: Administration, Oral; Angioplasty, Balloon; Animals; Arteriosclerosis; Aspirin; Cholesterol, Dietary; Disease Models, Animal; Drug Synergism; Epoprostenol; Femoral Artery; Iliac Artery; Injections, Subcutaneous; Male; Platelet Aggregation Inhibitors; Rabbits; Random Allocation; Recurrence | 1995 |
Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
Topics: Administration, Oral; Alprostadil; Animals; Aspirin; Bridged Bicyclo Compounds; Collagen; Diltiazem; Drug Evaluation, Preclinical; Epinephrine; Epoprostenol; Fatty Acids, Monounsaturated; Fibrinolytic Agents; Heparin; Hydralazine; Injections, Intravenous; Isosorbide Dinitrate; Male; Mice; Nifedipine; Nitroprusside; Platelet Aggregation Inhibitors; Pulmonary Embolism; Superoxide Dismutase; Vasodilator Agents | 1995 |
Prostacyclin analogue, beraprost, sustains recanalization duration after thrombolytic therapy in acute myocardial infarction model.
Topics: Animals; Aspirin; Coronary Thrombosis; Dogs; Drug Therapy, Combination; Epoprostenol; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Thrombolytic Therapy; Tissue Plasminogen Activator | 1993 |
Anti-inflammatory effects of beraprost sodium, a stable analogue of PGI2, and its mechanisms.
Topics: Alprostadil; Animals; Anti-Inflammatory Agents; Aspirin; Cell Membrane Permeability; Collagen; Dose-Response Relationship, Drug; Edema; Endothelium, Vascular; Epinephrine; Epoprostenol; Lung; Male; Mice; Organ Size; Pulmonary Embolism; Rats; Rats, Wistar; Serotonin | 1997 |
Mechanisms of relaxation induced by angiotensin II in isolated canine and human uterine arteries.
Topics: Adult; Aged; Angiotensin II; Animals; Arteries; Aspirin; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Epoprostenol; Female; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Platelet Aggregation Inhibitors; Tranylcypromine; Uterus; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2001 |
Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering.
Topics: Aspirin; Clopidogrel; Epoprostenol; Humans; Light; Particle Size; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Retinal Vein Occlusion; Scattering, Radiation; Ticlopidine | 2005 |
Comparison of antiplatelet potency of sarpogrelate, aspirin, and beraprost in healthy volunteers according to in-vitro closure time.
Topics: Adult; Aspirin; Epoprostenol; Female; Humans; Male; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Succinates | 2010 |
Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
Topics: Adult; Aged; Aged, 80 and over; Ankle Brachial Index; Aspirin; Cardiovascular Agents; Cardiovascular Diseases; Cilostazol; Disease Progression; Epoprostenol; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Quality of Life; Risk Assessment; Risk Factors; Severity of Illness Index; Societies, Medical; Tetrazoles; Time Factors; Treatment Outcome; Vascular Surgical Procedures; Vasodilator Agents | 2010 |
A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process.
Topics: Abciximab; Adenosine Triphosphate; Adult; Antibodies, Monoclonal; Area Under Curve; Aspirin; Blood Platelets; Blood Pressure; Collagen; Dose-Response Relationship, Drug; Epoprostenol; Equipment Design; Female; Humans; Immunoglobulin Fab Fragments; Lab-On-A-Chip Devices; Male; Microscopy, Video; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Regional Blood Flow; Stress, Mechanical; Thrombosis; Time Factors | 2012 |
Beneficial Effect of Beraprost Sodium Plus Aspirin in the Treatment of Acute Ischemic Stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Infarction; Drug Therapy, Combination; Epoprostenol; Female; Glomerular Filtration Rate; Humans; Ischemia; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome | 2017 |